BKYI · Insider Trading

BIO-key International, Inc. Common Stock

Every open-market purchase and sale reported by BKYI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
6
code P
Sales
0
code S
Reporting Insiders
8
current holders
BKYI — Recent Form 4 Transactions (latest 2026-07-02)
FiledInsiderRole TypeSharesValue
2026-07-02 Mira K Lacous Chief Technology Officer A +250 +$958
2026-07-02 Michael W Depasquale Chief Executive Officer A +250 +$958
2026-07-02 James David Sullivan Chief Legal Officer A +250 +$958
2026-01-05 Mira K Lacous Chief Technology Officer A +2,500 +$1.15K
2026-01-05 Michael W Depasquale Chief Executive Officer A +2,500 +$1.15K
2026-01-05 James David Sullivan Chief Legal Officer A +2,500 +$1.15K
2025-09-17 Michael W Depasquale Chief Executive Officer Buy +4,117 +$3.23K
2025-09-17 Michael W Depasquale Chief Executive Officer Buy +4,117 +$3.23K
2025-09-03 Michael W Depasquale Chief Executive Officer A +45,000 —
2025-09-03 Cecilia C Welch Chief Financial Officer A +35,000 —
2025-09-03 Mira K Lacous Chief Technology Officer A +25,000 —
2025-09-03 James David Sullivan Chief Legal Officer A +40,000 —
2025-08-26 James David Sullivan Chief Legal Officer Buy +10,000 +$7.70K
2025-07-02 Michael W Depasquale Chief Executive Officer A +139 +$97
2025-07-02 Mira K Lacous Chief Technology Officer A +139 +$97
2025-07-02 James David Sullivan Chief Legal Officer A +139 +$97
2025-06-16 Michael W Depasquale Chief Executive Officer Buy +5,000 +$3.90K
2025-06-04 Michael W Depasquale Chief Executive Officer Buy +4,000 +$3.32K
2025-06-03 Michael W Depasquale Chief Executive Officer Buy +5,000 +$4.05K
2025-05-27 Fong Wong Kwok Managing Director, BIO-key HK A +2,000 —
2025-05-27 Emmanuel Alia Director A +5,000 —
2025-05-27 Robert J Michel Director A +6,266 +$1.00K
2025-05-27 Cameron E. Williams Director A +6,266 —
2025-05-12 Cameron E. Williams Director A +3,897 —
2025-05-12 Emmanuel Alia Director A +3,897 —
2025-05-12 Robert J Michel Director A +3,897 —
2025-03-21 Emmanuel Alia Director A +2,971 —
2025-03-21 Cameron E. Williams Director A +2,971 —
2025-03-21 Robert J Michel Director A +2,971 —
2025-01-03 Mira K Lacous Chief Technology Officer A +139 +$195
2025-01-03 James David Sullivan Chief Legal Officer A +139 +$195
2025-01-03 Michael W Depasquale Chief Executive Officer A +139 +$195
2024-11-08 Cameron E. Williams Director A +2,587 —
2024-11-08 Robert J Michel Director A +2,587 —
2024-11-08 Emmanuel Alia Director A +2,587 —
2024-08-02 Emmanuel Alia Director A +3,500 —
2024-08-02 Cecilia C Welch Chief Financial Officer A +22,500 —
2024-08-02 Michael W Depasquale Chief Executive Officer A +24,000 —
2024-08-02 Michael W Depasquale Chief Executive Officer A +24,000 —
2024-08-02 Cameron E. Williams Director A +4,176 —
2024-08-02 Mira K Lacous Chief Technology Officer A +9,000 —
2024-08-02 James David Sullivan Chief Legal Officer A +22,500 —
2024-08-02 Robert J Michel Director A +4,176 —
2024-07-02 Michael W Depasquale Chief Executive Officer A +139 +$194
2024-07-02 James David Sullivan Chief Legal Officer A +139 +$194
2024-07-02 Mira K Lacous Chief Technology Officer A +139 +$194
2024-03-29 Robert J Michel Director A +1,429 —
2024-03-29 Cameron E. Williams Director A +1,429 —
2024-03-29 Emmanuel Alia Director A +1,429 —
2024-01-03 Mira K Lacous Chief Technology Officer A +139 +$354
BKYI — Current Insider Holders
InsiderRole Shares HeldValue
James David Sullivan Chief Legal Officer 12,295 $30.61K
Michael W Depasquale Chief Executive Officer 10,778 $26.84K
Cecilia C Welch Chief Financial Officer 5,940 $14.79K
Mira K Lacous Chief Technology Officer 4,076 $10.15K
Fong Wong Kwok Managing Director, BIO-key HK 3,525 $8.78K
Robert J Michel Director 2,357 $5.87K
Emmanuel Alia Director 2,132 $5.31K
Cameron E. Williams Director 2,068 $5.15K
BKYI Insider Trading FAQ
Who are the insiders at BKYI?
8 officers, directors and 10%+ beneficial owners currently report holdings in BKYI via SEC Form 4.
Are BKYI insiders buying or selling?
Across the 50 most recent Form 4 filings for BKYI, 6 were open-market purchases (code P) and 0 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is BKYI insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent BKYI filing is dated 2026-07-02.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the BKYI quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.